Nan Du

2.3k total citations · 1 hit paper
43 papers, 1.2k citations indexed

About

Nan Du is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Nan Du has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Immunology and 8 papers in Oncology. Recurrent topics in Nan Du's work include Macrophage Migration Inhibitory Factor (5 papers), Immunotherapy and Immune Responses (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Nan Du is often cited by papers focused on Macrophage Migration Inhibitory Factor (5 papers), Immunotherapy and Immune Responses (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Nan Du collaborates with scholars based in China, United States and Hong Kong. Nan Du's co-authors include Xiaosong Li, Fengyi Zhang, Jinfeng Wang, Xiaomin Xu, Yeping Wang, Peifeng Ji, Zhenyu Jia, Wenyu Shi, Zhi Zheng and Jiayong Zheng and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Nan Du

42 papers receiving 1.2k citations

Hit Papers

Dysbiosis of maternal and neonatal microbiota associated ... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nan Du China 18 450 255 208 200 156 43 1.2k
Satoshi Inoue Japan 26 789 1.8× 284 1.1× 234 1.1× 310 1.6× 135 0.9× 74 1.7k
Jinxiu Li China 10 501 1.1× 531 2.1× 171 0.8× 144 0.7× 82 0.5× 21 1.9k
Jiayi Yang China 10 477 1.1× 193 0.8× 105 0.5× 67 0.3× 119 0.8× 19 1.5k
Matthew Caley United Kingdom 17 632 1.4× 149 0.6× 163 0.8× 305 1.5× 135 0.9× 39 1.9k
Reiner Wimmer Austria 9 887 2.0× 198 0.8× 124 0.6× 284 1.4× 434 2.8× 9 2.5k
Yuqing Deng China 22 401 0.9× 262 1.0× 104 0.5× 105 0.5× 98 0.6× 95 1.6k
Patricia Prado Spain 5 538 1.2× 129 0.5× 157 0.8× 165 0.8× 314 2.0× 6 2.0k
María C. Leiva United States 14 233 0.5× 160 0.6× 107 0.5× 133 0.7× 95 0.6× 24 729
Tengfei Liu China 18 610 1.4× 478 1.9× 110 0.5× 336 1.7× 177 1.1× 53 1.6k

Countries citing papers authored by Nan Du

Since Specialization
Citations

This map shows the geographic impact of Nan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Du more than expected).

Fields of papers citing papers by Nan Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Du. The network helps show where Nan Du may publish in the future.

Co-authorship network of co-authors of Nan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Du. A scholar is included among the top collaborators of Nan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Du. Nan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chen, et al.. (2025). Exploring the role of LOX family in glioma progression and immune modulation. Frontiers in Immunology. 16. 1512186–1512186. 2 indexed citations
2.
Liu, Chen, et al.. (2024). Spermine Synthase : A Potential Prognostic Marker for Lower-Grade Gliomas. Journal of Korean Neurosurgical Society. 68(1). 75–96.
3.
Du, Nan, et al.. (2024). Decline in Working Memory in Stable Schizophrenia May Be Related to Attentional Impairment: Mediating Effects of Negative Symptoms, a Cross-Sectional Study. Neuropsychiatric Disease and Treatment. Volume 20. 149–158. 3 indexed citations
4.
Yang, Yanjie, Nan Du, Jingqin Ma, et al.. (2023). Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 1897–1910. 1 indexed citations
5.
Cao, Qing, Nan Du, Yu Li, et al.. (2021). Practical fine-grained learning based anomaly classification for ECG image. Artificial Intelligence in Medicine. 119. 102130–102130. 5 indexed citations
6.
Du, Nan, Qing Cao, Yu Li, et al.. (2020). FM-ECG: A fine-grained multi-label framework for ECG image classification. Information Sciences. 549. 164–177. 41 indexed citations
7.
Zhang, Xuejie, Bingqiang He, Hui Li, et al.. (2020). SOCS3 Attenuates GM-CSF/IFN-γ-Mediated Inflammation During Spontaneous Spinal Cord Regeneration. Neuroscience Bulletin. 36(7). 778–792. 16 indexed citations
8.
Zhu, Ziwen, Yue Zhou, Nan Du, et al.. (2019). MIF/CD74 axis participates in inflammatory activation of Schwann cells following sciatic nerve injury. Journal of Molecular Histology. 50(4). 355–367. 18 indexed citations
9.
Du, Nan, Zhenghe Xu, Min Gao, et al.. (2018). Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Li, Rongkun, Chun Zhuang, Shu‐Heng Jiang, et al.. (2017). ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer. Journal of Cancer. 8(18). 3764–3773. 24 indexed citations
11.
Zhao, Hui, Yan Fu, Fangfang Yao, et al.. (2016). Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study. Oncology Letters. 13(3). 1425–1431. 14 indexed citations
12.
Fu, Yan, Jia Hu, Nan Du, et al.. (2015). Bevacizumab plus chemotherapy versus chemotherapy alone for preventing brain metastasis derived from advanced lung cancer. Journal of Chemotherapy. 28(3). 218–224. 21 indexed citations
13.
Zhao, Hui, Xiaosong Li, Dianjun Chen, et al.. (2015). Intraperitoneal administration of cisplatin plus bevacizumab for the management of malignant ascites in ovarian epithelial cancer: results of a phase III clinical trial. Medical Oncology. 32(2). 292–292. 25 indexed citations
14.
Zhou, Feifan, Xiaosong Li, Mark F. Naylor, et al.. (2015). InCVAX – A novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity. Cancer Letters. 359(2). 169–177. 65 indexed citations
15.
Du, Nan, Kaiyu Jiang, Ashley Sawle, et al.. (2015). Dynamic tracking of functional gene modules in treated juvenile idiopathic arthritis. Genome Medicine. 7(1). 109–109. 13 indexed citations
16.
Fu, Yan, et al.. (2014). Expression of HSPA2 in human hepatocellular carcinoma and its clinical significance. Tumor Biology. 35(11). 11283–11287. 17 indexed citations
17.
Song, Lin‐Ping, et al.. (2013). Malposition of peripherally inserted central catheter: Experience from 3012 cancer patients. International Journal of Nursing Practice. 20(4). 446–449. 18 indexed citations
18.
Du, Nan, Xiaosong Li, Fang Li, et al.. (2013). Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion. Oncology Reports. 29(6). 2332–2340. 74 indexed citations
19.
Du, Nan, Xuetao Pei, Jinming Zhou, et al.. (2009). Transcriptional control of Flt3 ligand targeted by fluorouracil-induced Egr-1 promoter in hematopoietic damage. Journal of Biomedical Science. 16(1). 85–85. 1 indexed citations
20.
Wang, Wenshu, Yawei Zhou, Yun‐Hua Ye, & Nan Du. (2004). [Studies on the flavonoids in herb from Scutellaria barbata].. PubMed. 29(10). 957–9. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026